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The quality agenda, Quality, Innovation, Productivity and Prevention (QIPP), has clearly identified that the NHS must become more efficient and save £20 billion by the 
year 2014/15 (Department of Health [DH], 2008). Prevention, 
treatment and management of chronic wounds are inextricably 
linked to this initiative, especially as the cost of wound care 
to the NHS is so high. The QIPP Safe Care work stream has 
focused on reducing harm and associated expenditure across 
a range of areas, with the Chief Nursing Officer for England, in 
the High Impact Actions For Nursing And Midwifery, setting the 
specific challenge, that there should be no avoidable pressure 
ulcers in NHS-provided care (Beasley, 2010). 
    Financial costs of chronic wounds have been widely reported 
and discussed. Tennvall et al (2006) recounted that being able 
to accurately place a monetary cost on wound management 
was difficult owing to variables including length of time to 
healing, frequency of dressing changes and nursing time. 
The DH (2010) estimated that management and treatment of 
a grade 1 pressure ulcer would cost between £143 000 and 
£214 000, rising to between £447 000 and £668 000 for a grade 4. 
Posnett and Franks (2008) estimated venous leg ulceration 
would cost the NHS at least £168–98 million per year while 
Kerr (2012) estimated that between £600 million and nearly 
£700 million is spent each year on foot ulcers and amputations. 
A chronic wound is defined as any wound that has not healed 
for 6 weeks or more (Cutting and Tong, 2003). This includes 
pressure, diabetic foot, and leg ulcers. Surgical and traumatic 
wounds may also become chronic. The cost to health care 
of managing chronic wounds is not only financial, it can also 
affect the quality of life of the patient in terms of mobilisation, 
nutrition, sleep, social isolation, malodour, pain and infection. 
Accurate and timely assessment is essential and the patient 
should be engaged with assessment and treatment plans. 
Tennvall et al (2006) suggested using a structured approach 
to management, pointing out that appropriate treatment 
strategies reduce healing time and overall costs of care, and 
improve quality of life.
In order for practitioners to effectively manage chronic 
wounds, an evidence-based approach to interventions is 
essential. Education and skills development can be accessed 
via a range of methods including higher education institutions, 
study days, conferences or in-house study days/sessions.
This supplement will explore the challenges of wound 
assessment and investigate the cost of debridement and 
quality of life issues, focusing on the use of Debrisoft® as a 
debridement technique.  
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Figure 1
Accurate wound assessment is an essential skill 
required by all practitioners to effectively plan, 
implement and evaluate the care required for 
each patient (Ousey and Cook, 2011). Holistic 
assessment of the patient and the wound is vital 
to ensure accurate diagnosis of the underlying 
cause of the wound and identify factors that 
could delay wound healing. The World Union of 
Wound Healing Societies (2008) reminds us of 
the value of assessment and diagnosis in the 
treatment of wounds, highlighting the need for 
effective treatment for patients with wounds. The 
diagnostic process will:
• Determine the cause of the wound
• Identify any comorbidities/complications that  
may contribute to the wound or delay healing
• Assess the status of the wound
• Help to develop the management plan.
To ensure accurate assessment all 
practitioners involved in wound care should have 
sufficient training, knowledge and expertise 
(Wounds UK, 2008). There have been concerns 
raised around whether nurses are accurately 
undertaking wound assessment (Ashton and 
Price, 2006; McIntosh and Ousey, 2008; Dowsett, 
2009). Inappropriate wound management can 
result in failing to heal wounds, which increases 
patient suffering and the risk of complications 
(Wounds UK, 2008). McIntosh and Ousey’s (2008) 
study reiterated this, reporting that optimal care 
is not always provided by nurses, leading to 
delayed wound healing, increased pain, increased 
risk of infection and inappropriate use of wound 
products, all of which result in a reduction in 
quality of life. Every patient with a wound has the 
right to expect a good minimum standard of care, 
regardless of the cause of their wound or where 
that care is delivered (Fletcher, 2010). Therefore, 
practitioners need to provide accurate diagnoses, 
clear treatment goals and rationale of choice of 
dressings and therapies, and perform regular 
evaluation in addition to ensuring the most 
effective wound care is provided.
Wound-bed preparation is a concept that aims 
to provide a structured and systematic approach 
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to the management of chronic wounds. It 
concentrates on removal of barriers that impair 
wound healing. The International Advisory Board 
on Wound Bed Preparation (2004) developed 
the acronym TIME (T = Tissue, non-viable or 
deficient; I = Infection or inflammation; M = 
Moisture imbalance; E = Edge of wound, non-
advancing or undermined). TIME provides 
practitioners with a structured assessment 
tool that focuses the clinician on assessing 
the presence of non-viable tissue, infection or 
chronic inflammation, imbalance of moisture 
levels and assessment of wound edges, to 
ascertain whether they are advancing or there is 
evidence of undermining. 
Accurate wound-bed assessment will 
differentiate between viable and non-viable 
tissue. Non-viable or devitalised tissue includes 
eschar (black necrotic tissue) and slough. The 
physical appearance of the devitalised tissue 
depends on the moisture content; eschar is 
black and leathery. As the moisture levels 
increase, the appearance changes from black 
through shades of brown to yellow or grey 
(O’Brien, 2002). The presence of necrotic or 
non-vital tissue is common in chronic non-
healing wounds and its presence can delay 
wound healing. Removal of devitalised tissue 
has many benefits including providing an 
environment that promotes healing, lowering 
bacterial burden and reducing malodour. It 
also allows full inspection of the extent of the 
tissue damage (European Wound Management 
Association, 2004). Assessing the extent of tissue 
damage is important in all wounds, especially in 
diabetic foot and pressure ulcers. Categorisation 
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of pressure ulcers is difficult if the wound is 
covered with devitalised tissue (Figure 1), only 
when it has been successfully debrided is the 
true extent of the tissue damage evident  
(Figure 2).
For many wounds, more than one method 
of debridement may be required (Vowden and 
Vowden, 2002). Currently there is no clear 
evidence to support one method of debridement 
over another (Leaper, 2002). Therefore, the 
choice of method of debridement will depend on 
the wound type, location, practitioner knowledge 
and skills, patient choice and time frame. 
Mechanical debridement was historically 
associated with the use of ‘wet-to-dry’ gauze, 
which non-discriminatorily physically removes 
devitalised tissue from the surface of the 
wound, resulting in significant pain and damage 
to healthy tissue (Falabella, 2006). The main 
advantage of mechanical debridement is that 
it quickly removes non-viable tissue. Debrisoft 
(Activa Healthcare) has been designed to provide 
fast, effective mechanical debridement that is 
pain- and trauma-free (Bahr, 2011). Debrisoft 
(Figure 3) is a pad made from monofilament 
polyester fibres that is gently wiped over the 
wound bed. Debrisoft was valuable in the 
management of a patient with a mixed-disease 
leg ulcer as Figure 4 shows.
The patient in Figure 4 was known to have 
stenotic arterial disease of his peroneal and 
anterior tibial artery with an ankle brachial 
pressure index of 0.72. He was managed in 
three-layer modified compression with a moist 
hydrofibre as the wound contact layer. The 
wound had a thin layer of slough evident that 
was thicker towards the wound edges. Debrisoft 
was moistened and wiped over the wound for 
approximately 5 minutes visibly removing the 
slough. Upon review 2 weeks later (Figure 5), 
the wound had reduced in size and healthy 
granulation tissue was visible with no evidence 
of slough returning. 
Promoting debridement may not be the best 
option for all types of devitalised tissue. Necrotic 
tissue, as a result of peripheral arterial disease 
(Figure 6), should not be routinely debrided as 
this can increase the risk of infection in this 
specific patient group (Leaper, 2002). Holistic 
patient assessment will highlight evidence of 
peripheral arterial disease; if it is suspected, 
the patient will require referral to the vascular 
specialists to ascertain the extent of disease and 
undergo re-vascularisation before starting any 
form of debridement.
It is recognised that hard-to-heal wounds pose 
significant personal costs to those affected, as 
well as being costly for the NHS (Ousey and 
McIntosh, 2010). Accurate wound assessment 
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and the use of evidenced-based interventions 
will ensure high-quality, cost-effective treatment 
(World Union of Wound Healing Society, 2008). 
Wound-bed preparation needs to be combined 
with holistic wound assessment, which 
encompasses the patient’s psychological needs. 
This will result in a clear understanding of 
treatment aims and highlight where therapeutic 
interventions are required to accelerate healing. 
Wound debridement is commonly an initial aim 
within wound management and there is a wide 
variety of methods available, however, careful 
selection is required as the choice of method 
can be pivotal in achieving successful outcomes 
(O’Brien, 2002; Gray et al, 2011).
Debridement aims to remove the non-viable 
tissue; there are many options including 
autolytic, surgical, enzymatic, sharp,  
biological, chemical and mechanical. 
Each method has specific advantages and 
disadvantages that the practitioner needs  
to fully understand. Failure to use the correct 
method for any given wound may lead to further 
delays in healing, increased patient suffering, 
and an unnecessary increase in cost  
(Falabella, 2006).
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What	is	a	biofilm?
Biofilms are found throughout the natural 
and industrial world, coating rock surfaces in 
rivers and streams, colonising and corroding 
metal pipes, and inside water distribution pipes 
causing contamination. Until the late 1970s, the 
concept of a biofilm was largely unknown and 
scientists believed that most bacteria existed 
in a free-floating or planktonic form. During 
the 1980s and 90s, research confirmed that 
attached bacteria were organised in elaborate 
ways (Lawrence et al, 1991) and in 2000, the 
gene sequencing of Pseudomonas aeruginosa 
(P. aeruginosa) (the bacteria in cystic fibrosis 
biofilms) was discovered and, consequently, 
opened up new areas of biofilm research 
(Whiteley, 2001). 
The definition of a biofilm has evolved from the 
relatively simple concept of fine extracellular 
polymer fibrils enabling bacteria to anchor to 
surfaces (Marshall, 1976, cited by Donald and 
Costerton, 2002), to a more complex description: 
‘a microbially derived sessile community 
characterised by cells that are irreversibly 
attached to a substratum or interface or to each 
other’ (Donald and Costerton, 2002: 170). 
These cells are often embedded in an 
extracellular polymeric substance composed 
of proteins and polysaccharides. The biofilm 
structure enhances survival strategies ensuring 
that a percentage of the bacteria present 
will survive when presented with physical or 
chemical challenges (Dowd et al, 2008). 
It is estimated that more than 99% of 
bacteria in the natural environment exist in 
stable biofilms and this may also be the case 
in wounds (Costerton et al, 1999; James et 
al, 2008). Devitalised tissue has been shown 
to provide a habitat for P. aeruginosa biofilm 
in an animal model (Serralta et al, 2001) and 
tissue with confluent colonies of biofilm-like 
appearance have also been removed from 
patients with recurrent Staphylococcus aureus 
wound infections (Gotz, 2002). Percival and 
Bowler (2008) hypothesise that bacterial biofilms 
could have a significant effect on inflammation, 
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infection and healing, and fragments of biofilm 
have also been shown to slough off at intervals 
and spread infection to other locations within 
the body (Costerton, 1999). It is estimated 
that biofilms are associated with 65-80% 
of non-healing wounds leading to chronic 
inflammation and delayed healing (James et al, 
2008; Percival and Bowler, 2008). 
Why	do	some	practitioners	believe	chronic	
non-healing	wounds	contain	biofilm?	
Chronic wounds exhibit an impaired response 
to wound healing owing to a number of factors. 
These include decreased perfusion of oxygen 
to the wound, a shortage of growth factors, 
increased inflammatory cytokines, development 
of cell senescence (ageing), abnormal matrix 
metalloproteinase regulation, excessive 
neutrophils and the presence of necrotic tissue, 
slough and bacteria (Dow et al, 1999; Wolcott 
et al, 2008). The bioburden in the wound may 
comprise proteinaceous exudate, devitalised 
tissue and white blood cells, which may be 
visually identified as slough in the wound bed 
(Wolcott and Dowd, 2008). Hurlow and Bowler 
(2012) suggest that as the biofilm’s extracellular 
matrix develops into a macroscopic community, 
it may become visible to the naked eye, for 
example, in plaque on the tooth’s surface. The 
bacteria within the biofilm, however, cannot be 
seen by the naked eye; their three-dimensional 
structure is difficult to discern even using 
microscopes.   
Debridement	as	a	key	component		
of	anti-biofilm	strategy
An important factor in delayed wound healing 
is the presence of devitalised or necrotic 
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tissue in the wound bed (Vowden and Vowden, 
1999), and the evidence presented suggests that 
biofilms may form a habitat within the devitalised 
tissue, further disrupting the normal cascade of 
healing. Sharp debridement of devitalised tissue 
in the wound bed has been shown to significantly 
decrease the presence of microorganisms 
(Schultz et al, 2004), although the biofilm’s ability 
to re-form means that this strategy alone is 
insufficient. It may be necessary to use multiple 
strategies to manage potential wound biofilms.
Antibiotics	and	antiseptics
Antibiotics are thought to suppress the biofilm’s 
metabolic activity, although a large percentage of 
the biofilm is dormant at any one time, limiting 
antibiotic efficacy. Systemic antibiotics should be 
given when deep tissue infection is suspected, for 
example, in diabetic foot ulcers, or when system 
infection is confirmed (Rhoads et al, 2008).
Antiseptics can be considered as an ongoing 
strategy to suppress the biofilm following 
debridement and, where necessary, in 
conjunction with systemic antibiotics. Antiseptics 
have been shown to penetrate biofilms and 
destroy bacterial cells, however, informed choice 
should be made about the selection of antiseptic 
as some, for example, silver, have been shown to 
damage human proteins (Wilson et al, 2005 cited 
in Rhoads et al, 2008).  
Historical misunderstanding of the 
physiology of the wound biofilm may have led 
to inappropriate management strategies, e.g. 
long-term administration of antibiotic and 
topical antimicrobial therapies, without due 
consideration to adjunct therapies such as 
debridement. 
Antibiofilm	agents
Several antibiofilm agents have been identified 
and used successfully in the food and 
water industry, including Xylitol, lactoferrin, 
ethylenediaminetetraacetic acid (EDTA), 
gallnium and dispersin B, although there is 
limited research in wound models. These 
antibiofilm agents disrupt biofilm communication, 
intercellular matrix and metabolism. It is 
suggested that these agents are not toxic to 
human cells and, therefore, could potentially 
play a role in wound management in the future 
(Martineau and Dosch, 2007). 
Martineau and Dosch (2007) have demonstrated 
the anti-biofilm properties of EDTA when 
incorporated into a wound gel. The protein 
lactoferrin stimulates ‘twitching’, causing 
bacteria to move around rather than forming 
harmful clusters, and its affinity for iron prohibits 
biofilm growth. Iron is essential for the biofilm 
and so, by signalling that it is in short supply, the 
biofilm is discouraged (Singh et al, 2002). 
Xylitol is a naturally occurring substance, used 
in chewing gum, that has been shown to reduce 
the incidence of dental decay, possibly through 
the destruction of biofilms on the teeth (Burt, 
2006).In-vitro evidence related to the impact of 
topical antimicrobials as antibiofilm agents has 
indicated that silver and povidone-iodine have 
limited effect, whereas PHMB may have a positive 
impact in infected wounds (Wiegand et al, 2009). 
Lenselelink and Andriessen (2011) demonstrated 
that continuous application of PHMB within a 
biocellulose dressing (Suprasorb X + PHMB®) 
reduces biofilm.
Dressings
There is evidence that some wound dressings 
can sequester or trap and retain bacteria 
(Tachi et al, 2004; Ljungh, 2006), however, 
this can depend on the structure, fibres and 
chemicals present. Tachi et al (2004) studied 
the bacterial retention capacity of alginate 
dressings in comparison with hydrofibre 
dressings in an infected animal model. They 
concluded that significant variance existed, 
and bacterial retaining ability was greater in 
the hydrofibre dressing. They did not, however, 
study sequestration of bacterial biofilms. 
Ljungh et al (2006) examined the principles of 
hydrophobic interactions in dialkylcarbamoyl 
chloride (DACC) dressings to bind and 
remove bacteria from wounds, and found that 
when the dressings came into contact with 
moisture, bacteria were irreversibly bound and 
subsequently removed from the wound. Again, 
the study only looked at planktonic bacteria.   
Debridement	
Wound debridement has been described as 
a significant modality in the management of 
wound biofilms and it is likely that concurrent, 
rather than single, treatment episodes will be 
more effective at reducing the bioburden and 
supporting the immune response (Wolcott et 
al, 2008). Devitalised tissue in the wound bed 
The Missing Link 9
may increase inflammatory response and mask 
or mimic signs of infection (Kammerlander et 
al, 2005), and although debridement may be 
the appropriate treatment option (as previously 
described), challenges exist in the level of 
skill required to perform some aspects of 
mechanical debridement safely, for example, 
sharp and hydro debridement. To address this, 
a selective method of mechanical debridement 
has been developed and successfully evaluated 
in practice in a number of different types of 
wounds (Gray et al, 2011; Haemmerle et al, 
2011; Fumarola, 2012; Stephen-Haynes, 2012; 
Westgate and Cutting, 2012). 
Debrisoft is made of monofilament polyester 
fibres with a fleece–like wound contact surface 
designed to remove devitalised cells, slough 
and debris from the wound bed. Westgate and 
Cutting (2012) have demonstrated the removal 
of biofilm material on a solid surface using the 
Debrisoft debridement product.
The pad is moistened with the selected wound 
cleansing solution and passed over the wound 
surface using the appropriate pressure. It has 
been demonstrated that Debrisoft successfully 
removes debris, bacteria and haematoma from 
the wound bed and hyperkeratotic skin from 
lower limbs (Gray et al, 2011; Haemmerle et al, 
2011), while maintaining patient comfort (Bahr et 
al, 2011; Fumarola, 2012). The treatment episode 
can be achieved in as short as 2-3 minutes 
(Bahr et al, 2011), and no adverse medical device 
events have been recorded to date.
Debrisoft has been used as a debriding agent 
in a range of acute, traumatic, and chronic 
wounds where the focus has been on the 
removal of wound debris and potential biofilm 
while effectively managing the patient’s pain 
experience. Successful treatment episodes have 
informed appropriate interventions, reduced 
in-patient bed days and safe ongoing care by 
the patient’s nursing team (Fumarola, 2012; 
Stephen-Haynes, 2012; Gray et al, 2011). 
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The treatment of chronic wounds has been 
estimated to cost the NHS £2-3 billion, which 
equates to about 3% of the annual healthcare 
budget based on figures from 2005 to 2006 
(Posnett and Franks, 2007). However, with an 
ageing population and an increased incidence 
of concomitant factors such as obesity and 
diabetes, it is possible that this figure has 
increased significantly and will continue to 
do so (Upton and Hender, 2012). The cost to 
the NHS of dealing with the psychological 
consequences of chronic wounds is often 
overlooked but is estimated to be between 
£40.5 million and £85.5 million per year or £750 
per patient (Upton and Hender, 2012). 
Where possible, the practitioner’s aim is 
to reduce the symptoms that cause distress 
to patients and, ultimately, to heal wounds. 
Chronic wounds often contain necrotic or 
sloughy tissue, which can harbour bacteria 
and act as a barrier to healing (Vowden and 
Vowden, 2011). It is generally accepted that fast 
and effective debridement of devitalised tissue 
supports wound healing (Bahr et al, 2011). 
Hyperkeratosis (thickening of the outer layer 
of the skin) is another common concern. It is 
frequently seen in the lower leg of patients with 
venous disease. Traditional methods of removal 
of hyperkeratosis can be time consuming and 
may traumatise the skin. If dead skin cells can 
be removed quickly and safely, practitioners 
can then accurately assess the skin and initiate 
appropriate treatment. 
Benefits	to	the	patient
The benefits of rapid and effective wound healing 
for the patient should not be underestimated. 
The psychological consequences of living with  
a chronic wound are well documented. Upton 
and Hender (2012) suggest that patients with  
chronic wounds may experience negative 
emotions such as:
• Stress
• Concern about physical symptoms
• Lack of self-worth
• Despair.
Jones et al (2006) found that prolonged pain 
Quality of Life
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and malodour in patients with chronic wounds 
were associated with anxiety and stress. Mobility 
restrictions also impact negatively and have been 
described as one of the worst aspects of living 
with a chronic wound (Hamer et al, 1994). Green  
and Jester (2009) found the quality of life 
of sufferers of chronic venous ulcers is 
compromised by many issues including pain and 
social isolation. 
The studies cited here give a good indication 
of the significant impact chronic wounds have 
on patients’ quality of life and wellbeing both 
physically and psychologically. Pain, odour, 
restricted mobility and lack of self-worth can 
lead to life changes including giving up hobbies, 
reduced contact with family and friends and,  
for some, financial burden owing to loss of income.
Benefits	for	nursing	staff 
The recognised demographic changes mean the 
population of the UK is ageing and will continue 
to do so (Office of National Statistics, 2012). 
Chronic wounds and skin changes associated 
with venous disease, e.g. hyperkeratosis, most 
commonly occur in the older population. We are, 
therefore, likely to see increasing numbers of 
chronic wounds. 
Enhancing wound healing through effective 
debridement can lead to a reduction in overall 
treatment costs (Gray et al, 2011). In the current 
financial climate, the best possible use of 
available resources and time must be guaranteed. 
In terms of wound care, this means ensuring 
appropriate use of products through effective and 
timely assessment. 
Wound	debridement	
Successful debridement is often associated 
with a reduction in exudate, and odour, and the 
appearance of a healthy, granulating wound bed 
(Vowden and Vowden, 2011).
Additionally, when sloughy or necrotic tissue 
is present, it is difficult to assess the wound bed 
accurately. Removal of this tissue may allow more 
accurate assessment of the wound bed. 
Traditional methods of rapid wound 
debridement such as sharp debridement, 
hydrosurgery or ultrasonic therapy are considered 
potentially painful and harmful unless carried out 
by practitioners with specialist knowledge and 
skills. Because of the level of skill required to 
carry out rapid wound debridement,  
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district nurses, general nurses and other 
 non-specialists often choose  
dressings that facilitate autolytic debridement 
of necrotic or sloughy tissue. This is a useful 
method of debridement but may take a 
considerable amount of time to achieve a 
granulating wound bed. 
Debrisoft is a selective mechanical wound 
debridement product that is easy to use and 
requires a minimal level of skill. It is available 
on Drug Tariff and, unlike some forms of 
debridement, it can be used by generalist nurses 
on wards or in the patient’s home. In clinical 
trials (Bahr et al, 2011; Gray et al, 2011), it has 
been shown to be an effective debridement 
product. Bahr et al (2011) recruited 60 patients 
to a multi-centre trial. They included all wounds 
requiring debridement and excluded wounds 
that appeared infected or caused severe pain. 
The researchers noted a significant shift in 
the wound condition after three debridement 
sessions approximately 4 days apart (the mean 
duration of each debridement session was 
2.51 minutes). Bahr et al (2011) also identified 
that 95% of patients reported that they either 
experienced no pain or only slight discomfort 
of a short duration (mean: 2 minutes). The 
clinicians who used the product identified that 
it was convenient and easy to use (Bahr et al, 
2011). This may allay concerns nurses have over 
using rapid debridement products. 
Removal	of	hyperkeratosis
Traditional methods of removing this 
hyperkeratotic layer of dead skin cells can take 
a significant period of time and may cause 
trauma. They involve soaking the leg for up to 
20 minutes and the application of ointment-
based emollients to soften the dead skin cells 
and facilitate removal by forceps. This may have 
to be done on several occasions. Gray et al 
(2011) were able to remove hyperkeratotic skin 
in a patient with extensive hyperkeratosis with a 
single 5-minute treatment with Debrisoft . 
Referral	to	specialist	services
For some patients with infected or painful 
wounds, specialist input will still be necessary. 
However, having access to a rapid debridement 
product that is quick and easy to use, causes 
little or no pain in most patients (Bahr et al, 
2011; Gray et al, 2011) and requires no formal 
training is hugely beneficial. It gives generalist 
nurses the freedom to assess and, where 
appropriate, debride wounds, without having 
to refer to specialist services such as tissue 
viability specialists and leg ulcer clinics. 
The case study presented on page 12 highlights 
the benefits of speeding up wound debridement. 
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Case Study
Barbara Pritchard 
Tissue Viability Nurse  
North East Wales
Patient details
• Female
• 77 years old
• Admitted to hospital with cellulitis  
7th March 2011
Medical history 
None 
Wound history
Mrs H was admitted to hospital with cellulitis. She 
was referred to the tissue viability service because 
of superficial wounds to her lower leg. I suggested 
applying a non-adherent contact layer to the 
affected areas and covering with padding and toe-
to-knee bandage, and keeping the leg elevated.
Two weeks later, I was contacted again. Mrs H 
had been taking the dressings down herself and not 
following the advice of the nursing staff. The area 
had now deteriorated causing great concern to both 
her and her husband.
When I visited Mrs H, the wound was covered in 
thick slough and the exudate was bright green in 
colour (Figure 7). Mrs H was very upset, believing 
that the wound would never heal. It was the sight 
of the slough on her leg that was causing her the 
most concern, as it was not reducing. 
The leg was washed in warm water and Debrisoft 
was used, removing the majority of the slough 
(Figure 8). Mrs H was overwhelmed at the sight 
of the slough being removed and I reassured her 
that the wound would heal. A silver dressing was 
applied under toe-to-knee padding and bandaging. 
The leg was washed at each dressing change using 
warm water with an added emollient only. The 
dressing was renewed every 3 days for 2 weeks. 
Mrs H was discharged from hospital 9 days after 
my visit. She was referred to the cellulitis clinic as 
an outpatient and to the district nurses for dressing 
changes. After 2 weeks, the silver dressing was 
changed to non-adherent contact layer and toe-to-
knee padding and bandage. 
The wound went on to heal without any further 
problems and was completely healed within 
4 weeks of discharge.
Figure 7
Figure 8
The Missing Link 13
This supplement explores the challenges of 
wound assessment, the cost of debridement, 
and issues of quality of life, while focusing on 
Debrisoft as a debridement technique. 
Cook discusses the importance of accurate 
wound assessment, noting the lack of clear 
evidence favouring any one of the various 
methods of debridement over another (Leaper, 
2002).The choice of method depends on wound 
type, location, practitioner knowledge and skills, 
patient choice and time frame. Registered nurses 
must keep their skills and knowledge up to date 
(Nursing and Midwifery Council, 2010: 4). Those 
undertaking debridement must be competent 
in a range of techniques and possess the 
underpinning knowledge of anatomy, physiology 
and choice of technique. Each practitioner must 
be responsible for their education and skills 
development and should access educational 
support from their work place, higher education 
institutions, study days and conferences, and 
through reflecting on current evidence.  
Practitioners performing debridement  
should have:
• Good knowledge of relevant anatomy
• Understanding of the range of wound 
debridement methods available
• Capability to identify viable tissue and 
differentiate non-viable tissue
• Ability to manage pain and patient discomfort 
before, during, and after the procedure
• Appropriate skills to deal with complications 
(e.g. bleeding)
• Awareness of infection control procedures. 
(Vowden and Vowden, 2011:2)
Fumarola discusses wound biofilms, 
explaining that wound debridement had been 
described as a significant modality in their 
management. However, she cautions that 
although debridement may be the appropriate 
treatment option, challenges may exist in 
the level of skill required to perform some 
aspects of mechanical debridement safely, for 
example, sharp and hydro debridement. Before 
undertaking any form of debridement procedure, 
Vowden and Vowden (2011:3) advise that the 
practitioner ask the following questions:
• What is the cause of the wound?
• What is the aim of treatment?
• What are the risks and benefits of performing 
debridement?
• What speed of debridement is required?
• Which method would be most appropriate?
• Where are the skills and/or equipment 
required to perform the treatment?
Bianchi indicates that chronic wounds can 
have a significant impact on quality of life and 
wellbeing, both physically and psychologically. 
Therefore, the benefits of rapid and effective 
wound healing should not be underestimated. 
Preserving and enhancing patients’ wellbeing 
has been discussed by a specialist group 
of practitioners who produced a consensus 
definition (Wounds International, 2012).
Wellbeing is a dynamic matrix of factors, 
including physical, social, psychological and 
spiritual. Within wound healing, optimising 
an individual’s wellbeing will be the result 
of collaboration and interactions between 
clinicians, patients, their families and carers, 
the healthcare system and industry. Wounds 
International (2012) suggests that stakeholders 
should work together to improve wellbeing 
in a cost-effective and efficient way, through 
therapeutic partnerships with patients and their 
carers and shared decision making. The group 
recognised that industry colleagues should also 
make efforts to develop products that optimise 
efficacy and enhance quality of life.
Individual accurate wound assessment is 
essential in determining the most appropriate 
debridement technique. Practitioners must 
ensure their skills and underpinning knowledge 
are current to be able to safely execute any 
debridement technique. If the practitioner 
believes they do not have the requisite skills, 
assistance should be sought from a suitably 
qualified member of staff such as tissue viability 
specialists, podiatrists or medical staff. 
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